Prot #145515: NU UCSF15U05: A Phase 1b/2 Study of the Oral CDK4/6 Inhibitor LEE011 (Ribociclib) in Combination with Docetaxel plus Prednisone in Metastatic Castration Resistant Prostate Cancer

Project: Research project

Project Details

Effective start/end date5/25/1612/31/18


  • Prostate Cancer Clinical Trials Consortium, LLC (Prot #145515: NU UCSF15U05 // Prot #145515: NU UCSF15U05)
  • Novartis Pharmaceuticals Corporation (Prot #145515: NU UCSF15U05 // Prot #145515: NU UCSF15U05)